DataMeds AI reported revenue of $1.56M and net income of -$7.74M for the quarter ended Mar 2026, down 85.6% year over year. This income statement covers 10 quarters of results from Dec 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||
| Revenue | 0.04M | 5.67M | 12.41M | 10.86M | 7.79M | 3.01M | 1.67M | 1.56M | ||
| Cost of RevenueCost of Rev | 0.05M | 5.15M | 11.16M | 10.17M | 7.29M | 2.78M | 9.53M | 1.39M | ||
| Gross Profit | -0.00M | 0.52M | 1.25M | 0.69M | 0.51M | 0.23M | -7.86M | 0.17M | ||
| Operating items | ||||||||||
| Research & DevelopmentR&D | 0.07M | 0.34M | 0.80M | 0.01M | 0.96M | |||||
| Selling, General & AdministrativeSG&A | 0.08M | 0.57M | 1.80M | 4.35M | 31.17M | 4.86M | 30.17M | 4.13M | 4.87M | |
| Other Operating ExpensesOther Opex | 0.47M | 0.65M | 0.80M | 0.80M | 0.80M | 13.36M | 0.36M | |||
| Operating ExpensesOpex | 0.08M | 0.57M | 2.27M | 5.00M | 32.04M | 6.01M | 31.78M | 17.50M | 6.19M | |
| Operating IncomeOp. Inc | -0.08M | -0.57M | -1.74M | -3.75M | -31.35M | -5.50M | -31.55M | -25.35M | -6.02M | |
| EBIT | -0.08M | -0.57M | -1.74M | -3.75M | -31.35M | -5.50M | -31.55M | -25.35M | -6.02M | |
| Non-operating items | ||||||||||
| Non Operating Interest Expenses | 0.00M | 0.00M | 0.14M | 0.69M | 1.09M | 1.18M | 1.43M | 0.88M | 2.07M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.02M | 0.10M | 0.01M | 0.01M | -1.35M | -1.63M | 0.26M | |||
| Non Operating IncomeNon Op. Inc. | -0.00M | -0.00M | -0.12M | -0.58M | -1.08M | -1.17M | -2.77M | -2.50M | -1.73M | |
| Net income details | ||||||||||
| EBT | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Profit After TaxPAT | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Income from Continuing OperationsIncome (Continuing) | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Consolidated Net IncomeConsol Net Inc. | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Income towards Parent CompanyParent Net Inc | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Net Income towards Common StockholdersNet Income | -0.08M | -0.57M | -1.87M | -4.33M | -32.43M | -6.67M | -34.32M | -27.85M | -7.74M | |
| Additional items | ||||||||||
| EPS (Basic) | -0.09 | -0.63 | -1.93 | -4.58 | -31.23 | -5.40 | -23.07 | -19.62 | -3.70 | |
| EPS (Diluted) | -0.09 | -0.63 | -1.93 | -4.58 | -31.23 | -5.40 | -23.07 | -19.62 | -3.70 | |
| Shares Outstanding | 0.89M | 0.89M | 0.92M | 0.97M | 0.95M | 1.04M | 1.24M | 1.49M | 1.42M | 2.09M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.89M | 0.89M | 0.92M | 0.97M | 0.95M | 1.04M | 1.24M | 1.49M | 1.42M | 2.09M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.89M | 0.89M | 0.94M | 1.02M | 1.02M | 1.23M | 1.26M | 1.49M | 1.42M | 2.39M |
| EBITDA | -0.08M | -0.57M | -1.74M | -3.75M | -31.35M | -5.50M | -31.55M | -25.35M | -6.02M | |
| Interest ExpensesInt Expense | 0.00M | 0.00M | 0.14M | 0.69M | 1.09M | 1.18M | 1.43M | 0.88M | 2.07M |